May 31, 2017 / 1:08 PM / 2 months ago

BRIEF-Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24%

1 Min Read

May 31 (Reuters) - NICOX SA:

* REG-NICOX RECEIVES FDA APPROVAL OF ZERVIATE1 (CETIRIZINE OPHTHALMIC SOLUTION) 0.24%

* ‍u.s. Patent Protection Until at Least 2030​

* ‍PARTNERING DISCUSSIONS UNDERWAY FOR U.S. COMMERCIALIZATION RIGHTS​

* ‍TRADING IS EXPECTED TO RECOMMENCE SHORTLY AFTER ISSUANCE OF THIS PRESS RELEASE​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below